Find out how we connect targeted research expertise in academia to your business requirements. Discover how we accelerate business innovation and take care of the paperwork (hourly fees, fixed price, IP acquisition, seed funding)
Herein, we show that inhibition of antioxidant production through down-regulation of nuclear factor erythroid 2-related factor 2 pathway in oPMN, despite enhanced recruitment in the oral cavity, is associated with severe CP.
Comparison of Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes
